Healthcare News

Selskabsmeddelelse nr. 04/2026 Intern viden Coloplast reviderer de finansielle forventninger til organisk vækst og EBIT-vækst i faste valutakurser før særlige poster for regnskabsåret 2025/26,...

Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower...

FDA Issued Complete Response Letter Citing Outstanding Items Related to Chemistry, Manufacturing, and Controls and Non-Clinical Information  FDA Does not Request Additional Clinical Data Company...

DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement...

Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the...

PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.

Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ Patients...

VIVO System to be featured in educational sessions at HRS Accepted manuscripts for LockeT and VIVO are now published and available online FORT MILL, S.C., April 23, 2026 (GLOBE NEWSWIRE) --...

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”) set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an immediate...

Q1 2026 revenue Quarterly activity Revenue: €177.4m, up 2.6% at CER1 and on a like-for-like basis2Increase driven by EMEA (+4.5%), with an improvement in the situation in France, and by Asia...